Register for updates

 
 

Medicine & Health
RSS Feed
Slowing the Biological Clock
Monday, October 27, 2014 9:30:00 AM

TAU study finds neutralizing an immune system gene could improve the success of fertility treatments in women

Difficulty in conceiving a child is a major challenge for one in seven heterosexual couples in America, especially for those over the age of 35. Now a new discovery by researchers at Tel Aviv University and Chaim Sheba Medical Center at Tel Hashomer could boost the chances of conception in women undergoing in vitro fertilization (IVF) treatments.

Their new research reveals a linkage between the genes of the innate immune system — immunity with which human beings are born, rather than immunity they acquire during their lives — and ovarian longevity. The study, published recently in the Proceedings of the National Academy of Sciences, constituted the doctoral work of Dr. Shiri Uri-Belapolsky of TAU's Sackler School of Medicine. The research was led by Prof. Ruth Shalgi, of the Department of Cell and Developmental Biology at TAU's Sackler School of Medicine, Dr. Yehuda Kamari and Prof. Dror Harats of TAU's Sackler Faculty of Medicine and Sheba Medical Center, and Dr. Aviv Shaish of Sheba Medical Center.

According to research conducted on laboratory mice, the genetic deletion of the protein Interleukin-1 (IL-1), a key player in the innate immune system, could improve the number of eggs available for fertilization as well as improve the ovarian response to hormonal stimulation involved in IVF procedures. This could prove especially effective in women who initially respond poorly to hormonal treatment.

Neutralizing the risks

"We revealed a clear linkage between the genes of the innate immune system and female reproduction," said Dr. Uri-Belapolsky. "The results of our study, which point to neutralizing the effects of the IL-1 protein to slow down the natural processes that destroy the eggs, may set the basis for the development of new treatments, such as an IL-1 blockade that would raise the number of eggs recovered during an IVF cycle and reduce the amount of hormones injected into women undergoing the treatment."

The connection between IL-1 and fertility was discovered by accident in the course of research performed by the scientists on the role of IL-1 in atherosclerosis, the hardening of the arteries. In a surprise result of the research, the fertility lifespan of IL-1-deficient mice was found to be 20% longer than that of control wild-type mice.

Keeping the clock ticking

Female mammals, including humans, are born with a finite number of eggs and are subject to a biological clock that dictates the end of the reproductive lifespan at around 50 years of age. Over the past decade, a trend of postponing childbearing into advanced age has led to a corresponding upward trend in the number of IVF treatments. Inflammation has been reported to affect both IVF outcomes and the ovarian reserve adversely. "Identifying a possible culprit, such as Interleukin-1, may offer new insight into the mechanisms responsible for egg loss as well as practical interventions," the study reports.

"Our revelation is secured with a patent application, and naturally, further study in mice and in humans is required to examine this therapeutic opportunity," said Prof. Shalgi. "I believe we will take this research forward into human clinical trials. However, there is still research to be done before we can start these trials."




Latest News

Global Internet of Things (IoT) Consortium Establishes Investment Vehicle at TAU

Ramot, TAU's Business Engagement Center Company, to launch i3 Equity Partners on campus.

Amarel Green Joins AFTAU as Director of Development, Silicon Valley

Corporate attorney brings more than a decade of experience with technology industry to new position.

Economics in a President Trump World

National teleconference with Prof. Leonardo Leiderman and Michael Shaoul.

"Nice" Women Earn Less than Their More Assertive Counterparts

New TAU study confirms that nice women finish last.

AFTAU Launches #TAUgives on November 29

"Giving Tuesday" initiative enables PhD students from Ram Fishman Lab to provide hands-on sustainability training to farmers in India, Ethiopia and Nepal.

President-Elect Trump and the Future of the Middle East

Dayan Center director Prof. Uzi Rabi discusses what the US election means for the region in a national teleconference.

Discovery of Neurotransmission Gene May Pave Way for Early Detection of Alzheimer's Disease

Identification could lead to new diagnostic blood test and therapeutics, say TAU researchers.

AFTAU to Celebrate Opening of The Steinhardt Museum of Natural History at Annual Gala Dinner

Philanthropist, financier and investor Michael Steinhardt to be honored; Charles Bronfman and Lynn Schusterman to serve as co-chairs.

Combined Virtual Reality–Treadmill Training May Prevent Falls Associated with Parkinson's and Other Disorders

Intervention can be used in gyms, rehabilitation centers and nursing homes, TAU researchers say.

Harnessing Algae for the Creation of Clean Energy

TAU researchers discover algae can yield mass quantities of hydrogen, the world's cleanest energy source.

Enzyme Treatment of Gene May Reverse Effects of Alzheimer's

APOE gene is a promising target for therapeutic approaches to Alzheimer's, says TAU researcher.

Prof. Illana Gozes Receives Top RARE Gene Award

World-renowned neuroscientist and geneticist celebrated for "commitment to research and new therapies."

Neural Membrane's Structural Instability May Trigger Multiple Sclerosis

TAU researchers discover physical mechanism that may enable immune system attack.

The Steve Tisch School of Film and Television at TAU Hosts First Annual Influencer Award

Homeland executive producer and TAU alum Gideon Raff honored at September 14th reception.

contentSecondary
c

© 2016 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10002 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University